{
    "nctId": "NCT01777802",
    "briefTitle": "Immune Responses in Prostate, Lung, Melanoma and Breast Cancer Patients Following Stereotactic Body Radiotherapy (SBRT), Intensity Modulated Radiotherapy (IMRT) or Brachytherapy",
    "officialTitle": "Observational Study of Immune Responses in Prostate, Lung, Melanoma and Breast Cancer Patients Following Stereotactic Body Radiotherapy (SBRT), Intensity Modulated Radiotherapy (IMRT) or Brachytherapy",
    "overallStatus": "ACTIVE_NOT_RECRUITING",
    "conditions": "Prostate Cancer, Breast Cancer, Lung Cancer, Melanoma",
    "studyType": "OBSERVATIONAL",
    "phase": "N/A",
    "allocation": "N/A",
    "primaryPurpose": "N/A",
    "enrollmentCount": 97,
    "primaryOutcomeMeasure": "Change in immune biomarkers from baseline and after radiation treatments for breast, prostate, and lung cancers.",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* Hormone Refractory, Metastatic Prostate Cancer, Lung Cancer, and Melanoma or Breast Cancer\n\nExclusion Criteria:\n\n-Life expectancy of less than 3 months",
    "sex": "ALL",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}